Skip to main content
. 2016 May 30;7(28):43835–43851. doi: 10.18632/oncotarget.9699

Figure 2. Down regulation of LncRNA RP11-838N2.4 correlates with TMZ resistance and poor patient survival in GBM.

Figure 2

A. Average levels of lncRNA RP11-838N2.4 was detected by qRT-PCR in human primary GBM specimens and relapsed GBM specimens. B. Kaplan-Meier overall survival curve according to lncRNA RP11-838N2.4 expression levels in GBM patients (p = 0.032). *P < 0.05, **P < 0.01.